LCM
MYGN icon

Landscape Capital Management’s Myriad Genetics MYGN Stock Holding History

Landscape Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-152,773
Closed -$2.22M – 735
2022
Q4 		$2.22M Buy
+152,773
New +$2.85M 0.33% 68
2022
Q3 		– Sell
-57,293
Closed -$1.04M – 1051
2022
Q2 		$1.04M Buy
+57,293
New +$1.19M 0.14% 122
2020
Q4 		– Sell
-68,120
Closed -$888K – 397
2020
Q3 		$888K Buy
+68,120
New +$862K 0.16% 126

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Landscape Capital Management's MYGN Position: Q1 2023 in Review

Landscape Capital Management sold out of Myriad Genetics (MYGN) in Q1 2023, closing a stake of 152,773 shares — an estimated $2.22M sold.

Landscape Capital Management first reported a position in MYGN in Q3 2020 and held it in 3 quarters. The position peaked at $2.22M in Q4 2022. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2023.

  • Landscape Capital Management reported no remaining Myriad Genetics position as of Q1 2023 after selling out during the quarter.
  • Landscape Capital Management sold 152,773 Myriad Genetics shares in Q1 2023, an estimated $2.22M.
  • Landscape Capital Management first reported a position in Myriad Genetics in Q3 2020 and held it in 3 quarters.
  • Landscape Capital Management's Myriad Genetics position peaked at $2.22M in Q4 2022.
  • 190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.